PSTV

#4003
PLUS THERAPEUTICS, Inc. - Common Stock
5.8 2 USD
-9.49%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
5.82
5.82
Range Annuel
0.13
8.00
Changement quotidien
-9.49%
Changement Mensuel
+4.49%
Evolution sur 6 mois
+854.10%
Changement Annuel
+1906.90%
Clôture Précédente
6.4 3
Open
5.8 2
Low
5.8 2
High
5.8 2
Volume
22
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Nouvelles